Introduction to Ujvira 100mg Infusion:

UJVIRA 100MG INFUSION contains Ado-Trastuzumab Emtansine which belongs to the group of medicines called Antibody-Drug Conjugates. It is used to manage metastatic breast cancer (cancer that has been spread to other body parts from breasts). It can also be used to manage relapsing breast cancer in patients when complete manage is not achievable.

UJVIRA 100MG INFUSION will be administered to you only by an oncologist or by a trained professional into your vein. It is suitable for use in patients with high levels of human epidermal growth factor 2 (HER2) or hormone receptor positive metastatic breast cancer (cancer this is more sensitive for hormonal changes).

Before receiving UJVIRA 100MG INFUSION inform your doctor if you have any liver problems. UJVIRA 100MG INFUSION is not recommended for use in pregnant or breastfeeding women. Both men and women receiving UJVIRA 100MG INFUSION must use a suitable contraceptive method to avoid pregnancy while undergoing therapy with UJVIRA 100MG INFUSION.

The most common side effects of receiving this medicine are mouth ulcers, skin rashes, nausea, stomach upset, lack of sleep, tingling and numbness of hands and feet, muscle pain, joint pain, hair loss and urinary tract infections. Consult your doctor if any of these side effect worsens.

Uses of Ujvira 100mg Infusion:

Advanced and metastatic breast cancer

How to consume Ujvira 100mg Infusion:

UJVIRA 100MG INFUSION will be given to you only by a doctor or a nurse into the vein (intravenously).

Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition.